carbutamide

This page covers all carbutamide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sulfonylurea receptor 1, Kir6.2.

Targets

Sulfonylurea receptor 1, Kir6.2

Phase 2 pipeline (1)

• Burcol · Metabolic
  Burcol works by binding to the sulfonylurea receptor 1, Kir6.2, to stimulate insulin release from pancreatic beta cells.

Patent intelligence

• carbutamide patent landscape — aggregated cliff calendar, attackable patents, originator estates